Introduction
============

Interoception classically refers to the signaling, representation, and perception of internal bodily sensations coming from the viscera, e.g. heartbeats, gastric distension or visceral pain ([@nsy027-B16]). Interoceptive processes are the safeguards of homeostatic control and contribute to motivational and affective behaviors ([@nsy027-B85]). In the context of drug addiction, indirect evidence suggests that interoceptive processes underpin urges to take a drug, also known as drug craving ([@nsy027-B56]). For example, lesion studies implicate the insular cortex, a brain region supporting interoceptive states, in the phenomenon of craving ([@nsy027-B31]). Neuroimaging studies further reveal abnormalities in the morphometry, functional activity and connectivity of insular cortex in alcohol, cannabis and, also, tobacco users ([@nsy027-B9]; [@nsy027-B51]; [@nsy027-B32]). In addition to lesion and neuroimaging investigations, more direct evidence concerning the relationship between interoceptive ability and craving can be drawn from behavioral studies. Interoceptive ability (i.e. interoceptive accuracy) commonly measured using heartbeat tracking and heartbeat discrimination tasks ([@nsy027-B27]; [@nsy027-B12]). In the heartbeat tracking task, participants silently count their own heartbeats, by focusing their attention on their internal cues. In the heartbeat discrimination task, participants attend to both internal and external cues, judging the synchrony between their own heartbeats and sequences of tones either presented in synch or out of synch with their own heartbeats. In this task, participants flexibly switch attention between external and internal cues to integrate the perceptions for the synchronicity judgment. Interestingly, the interoceptive accuracy of alcohol-dependent subjects and drug users has only been tested using the heartbeat tracking task. Diminished interoceptive abilities are observed in these populations and this deficit is positively associated with both subjective craving sensations and alexithymia (e.g. difficulties in identifying and describing emotions) ([@nsy027-B2]; [@nsy027-B83]). We recently reported that alexithymia (a possible outcome of aberrant processing of bodily sensations) may play a role in alcohol use ([@nsy027-B10]). Indeed, the effective integration of interoceptive inputs is crucial for both subjective experience and social skills ([@nsy027-B61]; [@nsy027-B76]); i.e. skills typically impaired in alcohol and drug use disorders ([@nsy027-B23]; [@nsy027-B89]).

Oxytocin (OT) is a neuropeptide hormone that is mostly synthesized in the hypothalamus, and released into the bloodstream via the posterior pituitary gland ([@nsy027-B78]). OT receptors are present in central and peripheral tissues, including the brain, heart, gastrointestinal tract and uterus ([@nsy027-B29]). Many human studies focus on the impact of OT administration on social cognition. However, underlying mechanisms remain unclear, since rodent ligands for OT receptors are not selective for human OT receptors ([@nsy027-B59]; [@nsy027-B47]; [@nsy027-B70]; [@nsy027-B86], [@nsy027-B87]). Nevertheless, OT administration can increase trust and enhance the detection of emotional signals of others ([@nsy027-B21]; [@nsy027-B42]; [@nsy027-B75]; [@nsy027-B48]; [@nsy027-B88]; [@nsy027-B64]; [@nsy027-B38]). Relatedly, OT administration can also improve capacity for 'mind reading' (mentalization) ([@nsy027-B33]), empathy ([@nsy027-B37]; [@nsy027-B60]) and mimicry of angry faces ([@nsy027-B93]). One proposed mechanisms by which OT impacts emotional regulation is via the modulation of attention resources. Indeed, intranasal OT will preferentially increase attention toward social cues, such as emotional faces, compared with neutral or non-social cues ([@nsy027-B84]; Clark-Elford *et al.*, 2014; [@nsy027-B20]; [@nsy027-B22]; [@nsy027-B39]; [@nsy027-B68]). There is emerging interest in whether the modulation of interoceptive processing underpins the impact of the OT system on social cognition. OT is hypothesized to modulate attention toward interoceptive signals (i.e. precision of central interoceptive representations), which can inform generative models of emotional and selfhood ([@nsy027-B69]). Intranasal OT administration may not markedly influence performance on heartbeat discrimination in healthy human participants ([@nsy027-B92]), yet electrophysiological studies show that OT gates the transmission of viscerosensory afferent information ([@nsy027-B65]). Correspondingly, OT has a direct impact on neurons within nucleus of the solitary tract, the main visceroceptive relay within the brainstem ([@nsy027-B18]; [@nsy027-B40]).

Interestingly, a new wave of translational research suggests that OT administration can inhibit alcohol consumption. One clinical trial showed that intranasal OT attenuated alcohol withdrawal symptoms in alcoholic patients ([@nsy027-B94]). In rodents, the overexpression of OT receptors in mice reduces the rewarding proprieties of ethanol ([@nsy027-B4]) and OT injections decrease ethanol consumption, ethanol preference and ethanol-triggered dopamine release within the accumbens nucleus ([@nsy027-B66], [@nsy027-B67]; [@nsy027-B50]; [@nsy027-B43]). Such observations further implicate the OT system in the development and maintenance of addiction ([@nsy027-B54]; [@nsy027-B15]; [@nsy027-B46]). Indeed, in adolescent animals, OT exposure will reduce the expression of anxiety and protect against development of adult alcohol and drug seeking behaviors ([@nsy027-B11]; [@nsy027-B36]). These effects are bidirectional: Alcohol injection is known to inhibit endogenous OT release ([@nsy027-B26]). Again, Interoception appears to be an important mediator: The processing of bodily sensations is impaired in alcohol-dependent individuals and the degree of this impairment correlates with emotional impairments, including alexithymia. OT can improve the emotional skills of alexithymic individuals ([@nsy027-B49]), most likely through its impact on brain centers supporting both interoception and emotion ([@nsy027-B19]; [@nsy027-B45]; [@nsy027-B82]).

In summary, interoception is a crucial facet of emotional regulation, which seems to be impaired in alcohol-dependent individuals. OT is a facilitator of empathic emotional feelings and enhances afferent viscerosensory transmission. Moreover, OT may reduce alcohol withdrawal symptoms and diminish alcohol intake. We, therefore, sought to characterize the impact of intranasal OT on interoceptive processing in alcohol users. We hypothesized that interoceptive skills are negatively correlated with alcohol use severity and that OT administration improves interoception and hence can reduce the impairments observed in heavy alcohol users.

Finally, higher level of alexithymia, anxiety, and depression are usually observed in alcohol use disorder ([@nsy027-B24]). As these three conditions are associated with abnormal interoceptive profiles ([@nsy027-B62]; [@nsy027-B6]; [@nsy027-B28]; [@nsy027-B10]), we thought it crucial to account for them in our analyses. However, we did not have any fresh hypotheses regarding the influence of these variables.

Materials and methods
=====================

Participants
------------

Thirty-two male volunteers (mean age 25.1 years; range 18--36 years) took part in the experiment. Participants were recruited via advertisements placed around the University of Sussex and Brighton and Sussex Medical School. All participants were healthy individuals with no history of psychiatric or neurological diseases and were not taking medication. During the screening, participants were directly asked if they had any history or received any diagnostic of alcohol or drug use disorders. The average number of years of education was *M* = 16.9 (s.d. = 2.62). All participants gave their written informed consent and were compensated for their time. The study was reviewed and approved by the BSMS Research Governance and Ethics committee.

Procedure
---------

The study was conducted at the Clinical Imaging Science Center in Brighton, UK. Participants were told that the goal of the study was to explore the impact of OT on emotional regulation. The study was composed of three sessions. Participants were asked to abstain drinking 24 h before each session. Prior to any session, participants were breathalyzed and a urinary sample was collected to test for drug use. The urinary drug test was undertaken to confirm the absence of drug use to exclude drug use disorder. The alcohol test was undertaken to ensure that participants abstained before the sessions. In the case of positive results, the participant would be excluded. During the baseline session and following the consent, demographic data (e.g. age, education level) were recorded, a blood sample was collected and psychometric questionnaires were administered. A within-subject design was used; a drug sequence was randomly allocated to each participant for the second and third session. On the second and third sessions, each participant self-administered 40 IU of OT nasal spray (Syntocinon; Novartis, Basel, Switzerland) or placebo (same composition as Syntocinon except for OT) in the presence of the experimenter, and subsequently performed the behavioral tasks 40 min after the administration (see [Supplementary Material](#sup1){ref-type="supplementary-material"} for details regarding the nasal spray administration). The second and third sessions were separated by 2--3 days. One participant specified he was hungover on one of the sessions; his data were discarded from the analyses. We failed to collect blood from two participants. Plasma OT measures are detailed in [Supplementary Material](#sup1){ref-type="supplementary-material"}.

Questionnaires
--------------

### Alcohol use questionnaire

The Alcohol use questionnaire ([@nsy027-B55]) is a 15-item scale measuring in detailed way the quantity of alcohol consumption \[alcohol units (8 g) drunk per week; Units per week\]. Participants were asked to estimate the number of drinking days, the usual quantity consumed and their drinking pattern over the preceding 6 months. For the purpose of our study, we used only the drinking quantity (i.e. alcohol units per week). Following UK guidelines, alcohol consumption of 14 or less units of alcohol per week is considered as mild social drinking. Alcohol consumption of more than 14 units of alcohol per week is considered as harmful drinking or moderate-to-heavy drinking (<https://www.nhs.uk>).

### Toronto alexithymia scale-20 items

The Toronto alexithymia scale-20 items (TAS-20) ([@nsy027-B3]) consists of 20 items rated on a five-point Likert scale (from 1 'strongly disagree' to 5 'strongly agree'). The TAS-20 is composed of three factors. The first factor measures difficulties in identifying feelings, the second factor measures difficulties in describing feelings and the third factor measures the way the participant uses externally oriented thoughts. The total alexithymia score is the sum of responses across all 20 items. We only considered the total score in our analyses.

### Spielberger state/trait anxiety inventory

Trait anxiety was assessed using the Trait version of the Spielberger State/Trait Anxiety Inventory (STAI; [@nsy027-B79]). This questionnaire is composed of 20 questions, assessing trait anxiety with questions such as 'I lack self-confidence' and 'I have disturbing thoughts'. Participants were asked to answer each statement using a response scale (which runs from 1 'Almost never' to 4 'Almost always') in order to capture a stable dispositional tendency (trait) for anxiety.

### Beck depression index II

Symptoms and severity of depression were evaluated using the Beck depression index (BDI) ([@nsy027-B8]). Participants responded to 21 questions designed to assess the individual's level of depression (e.g. Sadness, pessimism, past failure etc.). The BDI items are scored on a scale from 0 to 3. All items were then summed for a BDI total score.

Interoceptive accuracy
----------------------

Interoceptive accuracy was gauged by the participants' ability to detect their own heartbeats using a heartbeat tracking task ([@nsy027-B74]) and a heartbeat discrimination task ([@nsy027-B90]; [@nsy027-B41]). During each task, heartbeats were indexed and recorded using sensitive pulse oximetry (standard for our laboratory). A soft finger sensor was used to avoid pressure-induced pulsatile sensation at the fingertip and to gain accurate timing of pulse onsets from oximetric waveform output (Nonin4600 pulse oximeter, Nonin Medical Inc. Plymouth, MN, USA). Participants' heartbeats were monitored and recorded with the pulse oximeter sensor mounting attached to their index finger. The task was composed of 20 trials.

For the heartbeat tracking task, participants were required to count their heartbeats during six randomized time windows of varying length (25, 30, 35, 40, 45 and 50 s) and, at the end of each time window, to report the number of heartbeats detected to the experimenter. To derive measures for interoceptive accuracy, heartbeat tracking scores were calculated on a trial-by-trial basis based upon the ratio of perceived to actual heartbeats 1 − (\|*n*beats~real~ − *n*beats~reported~\|)/((*n*beats~real~ + *n*beats~reported~)/2) ([@nsy027-B34]; [@nsy027-B27]). This measure calculates interoceptive accuracy, independent of the number of heartbeats in the trial by normalizing the absolute error in perceived heartbeats as a function of the overall number of heartbeats. Mean interoceptive accuracy was computed by averaging accuracy for all trials. Moreover, a measure of heart rate was computed for each trial.

For the heartbeat discrimination task, each trial consisted of ten tones presented at 440 Hz and having 100 ms duration, which were triggered by the heartbeat. Under the synchronous condition, stimuli were presented at the start of the rise of the pulse oximetry signal (i.e. indicator of cardiac systole [@nsy027-B57]). Under the asynchronous condition, a delay of 300 ms was inserted (i.e. diastolic phase). At the end of each trial, participants signaled to the experimenter whether they believed the tones to be synchronous or asynchronous with their heartbeats. Therefore, the outcome of each trial was binary (1= Accurate, 0= Inaccurate). Mean interoceptive accuracy for the heartbeat discrimination task was calculated as a ratio of correct to incorrect synchronicity judgments, for each participant. Moreover, a measure of heart rate was computed for each trial.

Statistical analyses
--------------------

Analysis of interoceptive tracking accuracy used linear mixed-effects models as the outcome was continuous. We analysed interoceptive discrimination accuracy using generalized linear mixed models as the outcome was binary (Inaccurate =0; Accurate =1; binomial family function), using the lme4 package ([@nsy027-B7]) in the R environment (version 3.4.2; [@nsy027-B71]). P values were computed using lmerTest package ([@nsy027-B44]).

Both types of interoceptive accuracy were analysed with drug (two levels: Placebo = 0; OT = 1), units of alcohol per week (continuous predictor), their interaction and control variables (heart rate, anxiety, depression, alexithymia and drug sequence) as fixed factors. Participants were treated as a random factor. In order to specify the random effect structure, we used a data-driven approach for both tasks ([@nsy027-B5]). Models including (i) random intercepts, (ii) random uncorrelated intercepts and slopes and (iii) random correlated intercepts and slopes were run. Models' goodness of fits were compared using likelihood ratio tests. For the tracking task, the model including random correlated intercepts and slopes explained more variance than the two other models (Model 1: AIC = −293.91; Model 2: AIC = −354.91; Model 3: AIC = −385.46; Models 1--2 comparison: *χ*^2^~(11)~ = 61.00; *P* \< 0.001; Models 2--3 comparison: *χ*^2^~(13)~ = 34.55; *P* \< 0.001; Models 1--3 comparison: χ^2^~(13)~ = 95.55; *P* \< 0.001). For the discrimination task, the model including random uncorrelated intercepts and slopes explained more variance than the model including random intercept alone (Model 1: AIC = 1687.4; Model 2: AIC =1684; *χ*^2^~(10)~ = 3.33; *P* \< 0.001). The model including random correlated intercepts and slopes did not adequately converge, even after rescaling and optimization.

All continuous predictor variables were centered. Plasma OT levels were missing for two participants from whom we were unable to collect blood samples. Generalized and linear mixed models omit cases with missing data. Therefore, to check the effect of plasma OT levels on accuracy, we ran a first version of our final models, restricted to the participants with plasma OT information. Thereafter, we ran a second model, similar to the first one, but including plasma OT levels as predictor (fixed factor). For both tasks, we compared the two models using likelihood ratio tests.

Results
=======

Sample description, psychometric measures and correlations
----------------------------------------------------------

Thirteen participants were drinking between \<14 alcohol units per week and were considered as mild social drinkers. Nineteen participants were drinking \>14 alcohol units per week and were considered as moderate-to-heavy drinkers. Means, standard deviations and ranges of psychometric measures, basal plasma OT level as well as interoceptive accuracy and heart rate were computed for both tasks ([Table 1](#nsy027-T1){ref-type="table"}). Correlations coefficients revealed no relationship between psychometric measures and basal plasma OT level ([Table 2](#nsy027-T2){ref-type="table"}). Table 1.Mean and standard deviations of psychometric measures, basal plasma OT level as well as interoceptive accuracy and heart rate for both tasksMeans.d.RangeTAS-2055.429.7636--74Units per week24.8218.094.8--69.50STAI48.1912.2122--66BDI12.849.980--48Basal plasma OT level (pg/ml)1.610.570.95--3.07Mean discrimination Accuracy (Placebo)0.530.130.30--0.85Mean discrimination Accuracy (OT)0.580.180.30--0.95Mean heart rate during the discrimination task (Placebo; bpm)64.079.9747.20--88.80Mean heart rate during the discrimination task (OT; bpm)66.6711.1546--80--88.10Mean tracking Accuracy (Placebo)0.780.120.55--0.97Mean tracking Accuracy (OT)0.680.230.25--0.97Mean heart rate during the tracking task (Placebo; bpm)62.129.8944.30--83.80Mean heart rate during the tracking task (OT; bpm)65.4511.1743.30--85.70Table 2.Correlations coefficients for psychometric measures and basal plasma OT levelTAS-20Units per weekSTAIBDIUnits per weekPearson Correlation0.192Sig. (two-tailed)0.301STAIPearson Correlation0.308−0.179Sig. (two-tailed)0.0910.337BDIPearson Correlation0.354−0.117**0.496\*\***Sig. (two-tailed)0.0510.5310.005Basal plasma OT levelPearson Correlation−0.1490.113−0.057−0.179Sig. (two-tailed)0.4400.5580.7700.352[^1]

Tracking task
-------------

Results of the mixed-effects regression model, for this task, are presented in [Table 3](#nsy027-T3){ref-type="table"}. Table 3.Mixed-effects regression model to explain accuracy on tracking task using predictors for OT/placebo (drug), alcohol intake (units per week) and their interaction, with heart rate (HR), anxiety (STAI), depression (BDI), alexithymia (TAS-20) and drug sequence as control variables, including all participantsβSEz value*P* value(Intercept)0.7940.02532.2540.000\*\*\*Drug--0.0780.034--2.2870.030\*Units per week--0.0020.001--1.6890.105HR--0.0050.002--3.3010.002\*\*STAI--0.0050.002--2.6870.013\*BDI0.0070.0023.1480.004\*\*TAS-20--0.0010.002--0.6760.506Sequence--0.0500.030--1.6890.102Drug\*Units0.0020.0021.2560.220[^2]

We found a main effect of OT on accuracy, with reduced accuracy under OT compared with placebo (β = −0.08, SE = 0.03, *P* = 0.03). The main effect of heart rate was significant: participants with lower heart rate were more accurate than participants with higher heart rate (β = −0.01, SE = 0.01, *P* = 0.002). A main effect of anxiety as well as a main effect of depression were found; anxiety was associated with reduced accuracy whereas depression was associated with increased accuracy (anxiety: β = −0.01, SE = 0.01, *P* = 0.013; depression: β = 0.01, SE = 0.01, *P* =0.004). No main effect of units per week or interaction between OT/placebo and units per week was observed.

In order to check the effect of plasma OT level on accuracy, we compared a model restricted to the participants with plasma OT information and a second one similar to the first one but including plasma OT levels as predictor. Adding plasma OT levels did not significantly improve the model fit \[*χ*^2^~(14)~ = 2.33; *P* = 0.13\]. Moreover, the main effect of plasma was not significant (β = 0.05, SE = 0.04, *P* = 0.16; see [Supplementary Tables S1 and S2](#sup1){ref-type="supplementary-material"}).

Discrimination task
-------------------

Results of the mixed-effects regression model, for the (interoceptive/exteroceptive, cross-modal) discrimination task, are presented in [Table 4](#nsy027-T4){ref-type="table"}. Crucially, we found a significant interaction between drug and units of alcohol (β = 0.02, SE = 0.01, *P* = 0.025): The more alcohol drunk, the more OT increases interoceptive accuracy compared with placebo ([Figure 1](#nsy027-F1){ref-type="fig"}). Table 4.Mixed-effects regression model to explain accuracy on discrimination task using predictors for OT/placebo (drug), alcohol intake (units per week) and their interaction, with heart rate (HR), anxiety (STAI), depression (BDI), alexithymia (TAS-20) and drug sequence as control variables, including all participantsΒSEz value*P* value(Intercept)0.0970.1070.9040.366Drug0.2360.1401.6860.092.Units per week--0.0020.005--0.3460.730HR--0.0130.006--2.0430.041\*STAI--0.0100.007--1.5110.131BDI--0.0040.008--0.4350.664TAS-200.0010.0080.1700.865Sequence0.0320.1370.2360.813Drug\*Unit0.0180.0082.2390.025\*[^3]

![Scatterplot illustrating the interaction between Drug (OT/Placebo) and alcohol units per week on interoceptive accuracy during the heartbeat discrimination task. The y-axis is displaying the difference between interoceptive accuracy under OT and under placebo, in percentage. The shaded area represents the SE.](nsy027f1){#nsy027-F1}

We also found a trend of main effect of drug on accuracy, with greater accuracy under OT than under placebo (β = 0.23, SE = 0.14, *P* = 0.092). A significant main effect of heart rate was also observed: participants with lower heart rate were more accurate than participants with higher heart rate (β = −0.01, SE = 0.01, *P* = 0.041).

No main effect of anxiety, depression and alexithymia or OT/placebo sequence was observed.

In order to check the effect of plasma OT level on accuracy, we compared one model, restricted to the participants with plasma OT information, to a second model, similar to the first one but including plasma OT levels as predictor. Adding plasma OT levels did not significantly improve the model fit \[χ^2^~(11)~ = 2.74; *P* = 0.10\]. Moreover, the main effect of plasma was not significant (β = −0.21, SE = 0.13, *P* = 0.10; see [Supplementary Tables S3 and S4](#sup1){ref-type="supplementary-material"}).

Discussion
==========

In this study, we examined interoceptive processing in alcohol users and characterized the impact of intranasal OT on these processes.

Our main findings were that OT administration was associated with a reduction of interoceptive accuracy on the tracking task. However, it tended to be associated with an increase of interoceptive accuracy on the discrimination task. Moreover, we found a significant interaction between OT and alcohol intake on the discrimination task: when compared with placebo, OT administration was associated with improved interoceptive accuracy in heavy drinkers, but not in mild social drinkers. Interestingly, we did not find any main effect of units of alcohol on either interoceptive tasks; indicating that (non-clinical) alcohol consumption alone did not seem to be a strong predictor of interoceptive accuracy. Unlike alcohol-dependent patients, these alcohol users do not seem to be markedly impaired in interoceptive accuracy (Ates Çöl *et al.*, 2016; [@nsy027-B83]). However, interaction between alcohol intake and OT was observed independently of heart rate, alexithymia, anxiety or depression (as we controlled for these potential confounds). Moreover, the fact that this interaction was found only in the discrimination task (and not in the tracking task) suggests that OT does not have a general impact on interoceptive processing.

Indeed, while these two tasks are often used interchangeably in the objective measurement of interoception, heartbeat discrimination and heartbeat tracking tasks involve different cognitive mechanisms ([@nsy027-B27], [@nsy027-B28]). Heartbeat tracking requires the participant to focus only on his/her internal cardiac sensations, whereas performance of the heartbeat discrimination task requires the participant to attend flexibly to, switch perception between, and integrate external (e.g. sound) and internal (e.g. actual heartbeat) cues. Therefore, in the discrimination task, this integration of both internal and external sensorial information is crucial for making accurate judgments of synchronicity. Although specific studies of the integration of internal and external cues have yet to be undertaken in alcohol use disorders, there is evidence to suggest that the multimodal integration of emotional information is impaired in alcohol-dependent individuals ([@nsy027-B52]; [@nsy027-B13]). For example, electroencephalography reveals a reduced amplitude and increased latency of event-related potentials during crossmodal emotional processing in alcohol-dependent patients. However, this deficit is not observed in binge drinking suggesting that sensory integration processes are more vulnerable to chronic alcohol use compared with more acute alcohol intoxication or other drinking patterns ([@nsy027-B53]; [@nsy027-B13]).

The ability to switch between internally and externally focused attention is evoked by the discrimination task. This capacity is impaired in specific psychiatric disorders, including obsessive and compulsive disorders ([@nsy027-B81]). A cognitive-physiological theory of 'alcohol myopia' suggests that alcohol allows drinkers to narrow their perceptual abilities in order to focus in more immediate and salient aspects of experience (e.g. externally oriented thoughts) ([@nsy027-B80]; [@nsy027-B25]). This is supported by the recent demonstration that alcohol disrupts key nodes within the salience network, suggesting compromised internal monitoring ([@nsy027-B58]; [@nsy027-B30]; [@nsy027-B32]). Interestingly, intranasal OT is proposed to direct attentional resources from internal to external cues, through concurrent modulation of functional connectivity within the ventral attention network and salience network ([@nsy027-B1]; [@nsy027-B77]; [@nsy027-B14]; [@nsy027-B92]). These elements, plausibly account for the different directions of OT effects on the two interoceptive tasks, and inform understanding of the potential mechanism through which OT enhances interoceptive discrimination accuracy in heavy drinkers compared with mild social drinkers.

The alcohol myopia theory suggests that heavy drinkers are biased toward the processing of interoceptive cues and consequently experience difficulty in switching attention to exteroceptive one. Heavy drinkers, before marked alcohol-induced neurodegeneration, may not be overtly impaired and might employ compensatory mechanisms to manage deficits in attentional switching. However, we expect deficits become exacerbated and pathological with prolonged heavy drinking. The expression of such deficits may be mitigated by OT: As already mentioned, intranasal OT increases attentional resources toward exteroceptive stimulations. Correspondingly, we showed OT-induced reduction of accuracy during interoceptive tracking. Indeed, as the tracking task mainly involves internally focused attention ([@nsy027-B27]), OT may directly weaken attentional resource allocation toward bodily sensations, compromising interoceptive performance, and perhaps boost the capacity to switch from internal to external focused attention. Alternatively, by increasing externally focused attention, OT may potentiate the integration of internal--external inputs. These complementary mechanisms can also explain why OT tended to increase interoceptive accuracy on the discrimination task and why heavy drinkers, potentially less able to switch between internal and external cues, show a greater benefit from OT administration than mild social drinkers. Our findings are also consistent with a model arising from a predictive coding framework, in which OT is proposed to modulate the precision of interoceptive signals (i.e. narrowing the attribution of salience to internal bodily signals). This neuromodulation allows attentional deployment toward relevant external cues and, thereby favors associative learning between internal and external cues, a process fundamental to social cognition ([@nsy027-B69]).

Our results of this study should be considered in light of several constraints. First, low heart rate is associated with increased accuracy on cardiac interoceptive tasks, an effect that we also observed on both heartbeat tracking and discrimination tasks. Relatedly, beliefs about heart rate may further influence heartbeat counting performance ([@nsy027-B72]; [@nsy027-B73]). We managed this issue by including heart rate as a co-variable in analyses to account for its bias on cardioception. A second limitation of the study is the generalization of our findings to other dimensions of interoception. Even if it has been shown that cardioception aligns with sensitivity to gastric functions ([@nsy027-B35]), it would be interesting to investigate this relationship in alcohol use disorders. Finally, a last important constraint was that our sample was composed only of males to avoid taking menstrual cycle variability in our within-subject design. Further studies are needed to verify if our findings regarding OT modulation of attentional resources are generalizable to women. Finally, we measured basal plasma OT level to account for inter-individual differences. However, knowledge of the relationship between central and peripheral endogenous OT, and pharmacokinetic aspects of intranasal OT action remain rudimentary ([@nsy027-B70]; [@nsy027-B86], [@nsy027-B87]).

In conclusion, this study is, to date, the first study to examine the impact of OT on interoceptive performance accuracy in relation to non-clinical alcohol use. Our results do not suggest pure interoceptive impairment in alcohol users, but instead highlight a potential reduced flexibility of attentional resource allocation between internal and external cues; importantly, this impairment might be mitigated by acute intranasal OT intake. In this study, attention mechanisms are suggested to explain the relationship between OT and interoception in alcohol users. However, this hypothesis needs to be explicitly tested in future research. Nevertheless, our findings may usefully inform the development of new therapeutic approaches in alcohol and drug use disorders, potentially targeting mechanisms of attentional control and switching between interoceptive and exteroceptive sensory representations. Further studies involving neuroimaging will be helpful to build on this mechanistic understanding.
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